News on Takeda Pharmaceuticals North America%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Takeda Pharmaceuticals North America%2C Inc. news from BioPortfolio.com Tue, 09 Feb 2010 23:10:34 GMT en Outlook roundup: Ista Pharmaceuticals, Agcohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037219&HITNO=0&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037219&THISHREF=http://c.moreover.com/click/here.pl%3fz2536971065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037219&HITNO=0&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037219&THISHREF=http://c.moreover.com/click/here.pl%3fz2536971065%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Outlook roundup: Ista Pharmaceuticals, Agcohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037495&HITNO=1&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037495&THISHREF=http://c.moreover.com/click/here.pl%3fz2537111943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037495&HITNO=1&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037495&THISHREF=http://c.moreover.com/click/here.pl%3fz2537111943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAP via Yahoo!: Outlook roundup: Ista Pharmaceuticals sees 2010 profit, Agco expects boost from Brazilhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037466&HITNO=2&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037466&THISHREF=http://c.moreover.com/click/here.pl%3fz2537092668%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037466&HITNO=2&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037466&THISHREF=http://c.moreover.com/click/here.pl%3fz2537092668%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDCExaminer.com: Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedothttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=3&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=3&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Pharmaceutical Outsourcing: Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedulehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038207&HITNO=4&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038207&THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038207&HITNO=4&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038207&THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Takeda launches osteosarcoma medicine Mepact in EUhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=5&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=5&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Thought Leader Panel Assesses Anticoagulants Market in New MedPredict Reporthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026707&HITNO=6&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026707&THISHREF=http://c.moreover.com/click/here.pl%3fz2531200044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026707&HITNO=6&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026707&THISHREF=http://c.moreover.com/click/here.pl%3fz2531200044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRWeb: Angiotech Pharmaceuticals Announces Conference Call and Webcasthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026074&HITNO=7&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026074&THISHREF=http://c.moreover.com/click/here.pl%3fz2530335260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026074&HITNO=7&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026074&THISHREF=http://c.moreover.com/click/here.pl%3fz2530335260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Optimer Pharmaceuticals Announces Positive Results From Second Fidaxomicin Phase 3 Study in Patients With Closhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026069&HITNO=8&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026069&THISHREF=http://c.moreover.com/click/here.pl%3fz2530334491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026069&HITNO=8&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026069&THISHREF=http://c.moreover.com/click/here.pl%3fz2530334491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: OTC Pharmaceuticals - North America (NAFTA) Industry Guide- By Bharatbookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026879&HITNO=9&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026879&THISHREF=http://c.moreover.com/click/here.pl%3fz2531470945%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026879&HITNO=9&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026879&THISHREF=http://c.moreover.com/click/here.pl%3fz2531470945%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRMinds: Angiotech Pharmaceuticals Announces Conference Call and Webcasthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025348&HITNO=10&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025348&THISHREF=http://c.moreover.com/click/here.pl%3fz2529679233%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025348&HITNO=10&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025348&THISHREF=http://c.moreover.com/click/here.pl%3fz2529679233%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinancials.com: Optimer reports positive results from second Phase III study of antibiotic drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023922&HITNO=11&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023922&THISHREF=http://c.moreover.com/click/here.pl%3fz2528488693%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023922&HITNO=11&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023922&THISHREF=http://c.moreover.com/click/here.pl%3fz2528488693%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: TopoTarget Partner, Spectrum Pharmaceuticals, to host Conference Call Thursday 4 February 2010 at 19:00 CET (1http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=12&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=12&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: TopoTarget signs co-development and commercialization agreement with Spectrum Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022677&HITNO=13&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022677&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022677&HITNO=13&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022677&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Optimer Pharmaceuticals Announces Positive Results From Second Fidaxomicin Phase 3 Study in Patients With Closhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019342&HITNO=14&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019342&THISHREF=http://c.moreover.com/click/here.pl%3fz2526234474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019342&HITNO=14&MSIZE=520&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Takeda%20Pharmaceuticals%20North%20America,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019342&THISHREF=http://c.moreover.com/click/here.pl%3fz2526234474%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: